Open AccessThrombectomy in DAWN- and DEFUSE-3-Ineligible Patients: A Subgroup Analysis From the BEST Prospective Cohort Study
Author(s) -
James E. Siegler,
Steven R. Messé,
Heidi Sucharew,
Scott E. Kasner,
Tapan Mehta,
Niraj Arora,
Amy Starosciak,
Felipe De Los Rios La Rosa,
Natasha R Barnhill,
Akshitkumar M. Mistry,
Kishan Patel,
Salman Assad,
Amjad Tarboosh,
Katarina Dakay,
Sanjana Salwi,
Jeff Wagner,
Alicia Bennett,
Bharathi Jagadeesan,
Christopher Streib,
Sydney Weber,
Rohan Chitale,
John Volpi,
Stephan A. Mayer,
Shadi Yaghi,
Mahesh Jayaraman,
Pooja Khatri,
Eva Mistry
Publication year - 2019
Publication title -
neurosurgery/neurosurgery online
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.455
H-Index - 198
eISSN - 1081-1281
pISSN - 0148-396X
DOI - 10.1093/neuros/nyz485
Subject(s) - medicine , prospective cohort study , odds ratio , surgery , observational study , subgroup analysis , intracerebral hemorrhage , confidence interval , subarachnoid hemorrhage
Because of the overwhelming benefit of thrombectomy for highly selected trial patients with large vessel occlusion (LVO), some trial-ineligible patients are being treated in practice.